Local newsNews

Bacterial infections getting too clever for antibiotics

“As we gather more evidence, we see more clearly and more worryingly how fast we are losing critically important antimicrobial medicines all over the world.”

Data provided shows that a number of bacterial infections are increasingly resistant to the medicines at hand to treat them.

A record number of countries are now keeping a close eye and reporting on antibiotic resistance marking a major step forward in the global fight against drug resistance.

High rates of resistance among antimicrobials frequently used to treat common infections, such as urinary tract infections or some forms of diarrhoea, indicate that the world is running out of effective ways to tackle these diseases.

Also read: Covid-19: Six million people worldwide test positive (VIDEO)

For example, the rate of resistance to ciprofloxacin, an antimicrobial frequently used to treat urinary tract infections, varied from 8.4 per cent to 92.9 per cent, in 33 reporting countries.

“As we gather more evidence, we see more clearly and more worryingly how fast we are losing critically important antimicrobial medicines all over the world,” said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organisation (WHO).

“This data underscores the importance of both protecting the antimicrobials we have and developing new ones, to effectively treat infections, preserve health gains made in the last century and ensure a secure future.”

Since the WHO’s Global Antimicrobial Resistance and Use Surveillance System (GLASS) report in 2018, participation has grown exponentially.

In only three years of existence, the system now aggregates data from more than 64 000 surveillance sites with more than two million patients enrolled from 66 countries across the world.

Also read: Covid-19 disrupts health services for non-communicable diseases

In 2018 the number of surveillance sites was 729 across 22 countries.

More countries are also reporting on the recently approved indicator on antimicrobial resistance (AMR) as part of the Sustainable Development Goal Monitoring.

“The enormous expansion of countries, facilities and patients covered by the new AMR surveillance system allows us to better document the emerging public health threat of AMR,” said Dr Hanan Balkhy, assistant director-general for antimicrobial resistance at the WHO.

The WHO is alarmed that the trend will further be fuelled by the inappropriate use of antibiotics during the Covid-19 pandemic.

The organisation has issued guidance not to provide antibiotic therapy or prophylaxis to patients with mild Covid-19 or to patients with suspected or confirmed moderate Covid-19 illness, unless there is a clinical indication to do so, because evidence shows that only a small proportion of Covid-19 patients need antibiotics to treat subsequent bacterial infections.

Balkhy said, “We believe this clear guidance on the use of antibiotics in the Covid-19 pandemic will help countries tackle Covid-19 effectively and prevent the emergence and transmission of antimicrobial resistance (AMR) in the context of the pandemic.”

Also read: Covid-19: ‘We are not out of the woods yet’ – Karim

The WHO remains concerned by declining investment (including in the private sector) and lack of innovation in the development of new antimicrobial treatments – factors that are undermining efforts to combat drug-resistant infections.

“We must bolster global cooperation and partnerships, including between the public and private sectors to provide financial and non-financial incentives for the development of new and innovative antimicrobials,” added Balkhy.

To support this effort, the WHO has released two documents on target product profiles to guide development of new treatments for common resistant bacterial infections, and an economic model that simulates the costs, risks and possible return on investment of antibacterial drug development.

Dear reader,
As your local news provider, we have the duty of keeping you factually informed on Covid-19 developments. As you may have noticed, mis- and disinformation (also known as “fake news”) is circulating online. Caxton Local Media is determined to filter through the masses of information doing the rounds and to separate truth from untruth in order to keep you adequately informed. Local newsrooms follow a strict pre-publication fact-checking protocol. A national task team has been established to assist in bringing you credible news reports on Covid-19.

At Caxton, we employ humans to generate daily fresh news, not AI intervention. Happy reading!
You can read the full story on our App. Download it here.

Marietta Lombard

Editor-in-Chief of Caxton Joburg Metro with 26 years' experience in the community newspaper industry. I serve as Gauteng Director and deputy executive director of the Forum of Community Journalists and I am a press representative of the Press Council SA.

Related Articles

Back to top button